Is a normal TSH synonymous with "euthyroidism" in levothyroxine monotherapy?

Journal of Clinical Endocrinology and Metabolism

Volumn 101, Issue 12, 2016, Pages 4964-4973

  Peterson, Sarah J ^a   McAninch, Elizabeth A ^a   Bianco, Antonio C ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LEVOTHYROXINE; LIOTHYRONINE; LOW DENSITY LIPOPROTEIN; THYROTROPIN; THYROXINE; TRIACYLGLYCEROL;

ADULT; AGE; ARTICLE; BODY MASS; CALORIC INTAKE; CONTROLLED STUDY; EUTHYROIDISM; FEMALE; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; HUMAN; MALE; METABOLIC EQUIVALENT; MONOTHERAPY; PRIORITY JOURNAL; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; UNITED STATES; AGED; BLOOD; CROSS-SECTIONAL STUDY; HEALTH SURVEY; HYPOTHYROIDISM; MIDDLE AGED; THYROID FUNCTION TEST;

ADULT; AGED; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SURVEYS; HUMANS; HYPOTHYROIDISM; MALE; MIDDLE AGED; THYROID FUNCTION TESTS; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 85003633125     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2016-2660     Document Type: Article

References (32)

1. Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement. Thyroid. 2014;24: 1670-1751
2. Wiersinga WM, Duntas L, Fadeyev V, Nygaard B, Vanderpump MP. 2012 ETA Guidelines: The use of L-T4 - L-T3 in the treatment of hypothyroidism. Eur Thyroid J. 2012;1:55-71
3. McAninch EA, Bianco AC. The history and future of treatment of hypothyroidism. Ann Intern Med. 2016;164:50-56
4. Braverman LE, Ingbar SH, Sterling K. Conversion of thyroxine (T4) to triiodothyronine (T3) in athyreotic subjects. J Clin Invest. 1970; 49:855-864
5. Gereben B, McAninch EA, Ribeiro MO, Bianco AC. Scope and limitations of iodothyronine deiodinases in hypothyroidism. Nat Rev Endocrinol. 2015;11:642-652
6. Saravanan P, Chau WF, Roberts N, Vedhara K, Greenwood R, DayanCM.Psychological well-being in patients on 'adequate' doses of l-thyroxine: Results of a large, controlled community-based questionnaire study. Clin Endocrinol. 2002;57:577-585
7. Samuels MH, Kolobova I, Smeraglio A, Peters D, Purnell JQ, Schuff KG. Effects of levothyroxine replacement or suppressive therapy on energy expenditure and body composition. Thyroid . 2016;26:347-355
8. Gullo D, Latina A, Frasca F, Le Moli R, Pellegriti G, Vigneri R. Levothyroxine monotherapy cannot guarantee euthyroidism in all athyreotic patients. PloS One. 2011;6:e22552
9. al-Adsani H, Hoffer LJ, Silva JE. Resting energy expenditure is sensitive to small dose changes in patients on chronic thyroid hormone replacement. J Clin Endocrinol Metabol. 1997;82:1118-1125
10. Werneck de Castro JP, Fonseca TL, Ueta CB, et al. Differences in hypothalamic type 2 deiodinase ubiquitination explain localized sensitivity to thyroxine. J Clin Investig. 2015;125:769-781
11. Escobar-Morreale HF, Obregon MJ, Escobar del Rey F, Morreale de Escobar G. Replacement therapy for hypothyroidism with thyroxine alone does not ensure euthyroidism in all tissues, as studied in thyroidectomized rats. J Clin Investig. 1995;96:2828-2838
12. Taylor PN, Iqbal A, Minassian C, et al. Falling threshold for treatment of borderline elevated thyrotropin levels-balancing benefits and risks: Evidence from a large community-based study. JAMA Intern Med. 2014;174:32-39
13. Vanderpump MP. The epidemiology of thyroid disease. Br Med Bull. 2011;99:39-51
14. Medicines UseandSpending in the U.S.:AReview of2015andOutlook to 2020. Parsippany, NJ: IMS Institute for Healthcare Informatics; 2016
15. National Center for Health Statistics. National Health and Nutrition Examination Survey Data 2001-2002; http://wwwn.cdc.gov/nchs/nhanes/search/nhanes01-02.aspx. Accessed October 5, 2016
16. National Center for Health Statistics. National Health and Nutrition Examination Survey Data 2007-2008; http://wwwn.cdc.gov/Nchs/Nhanes/Search/nhanes07-08.aspx. Accessed October 5, 2016
17. National Center for Health Statistics. National Health and Nutrition Examination Survey Data 2009-2010; http://wwwn.cdc.gov/Nchs/Nhanes/Search/nhanes09-10.aspx. Accessed October 5, 2016
18. National Center for Health Statistics. National Health and Nutrition Examination Survey Data 2011-2012; http://wwwn.cdc.gov/Nchs/Nhanes/Search/nhanes11-12.aspx. Accessed October 5, 2016
19. National Center for Health Statistics. National Health and Nutrition Examination Laboratory Protocol. http://www.cdc.gov/nchs/nhanes/nhanes2001-2002/lab-methods-01-02.htm. Accessed October 5, 2016
20. IBM SPSS Statistics for Windows. Version 22.0. Armonk, NY: IBM Corp; Released 2013
21. Abdalla SM, Bianco AC. Defending plasma T3 is a biological priority. Clin Endocrinol. 2014;81:633-641
22. Cobb WE, Jackson IM. Drug therapy reviews: Management of hypothyroidism. American journal of hospital pharmacy. 1978;35(1): 51-58
23. Jackson IM, Cobb WE. Whydoes anyone still use desiccated thyroid USP?. Am J Med. 1978;64:284-288
24. Stock JM, Surks MI, Oppenheimer JH. Replacement dosage of L-thyroxine in hypothyroidism. A re-evaluation. N Engl J Med. 1974;290:529-533
25. Ingbar SH, Woeber KA. Thyroid hormone deficiency. In: Williams RH, ed. Textbook of Endocrinology. 5th ed. W. B. Saunders Company; 1974:191-212
26. Sawin CT, Surks MI, London M, Ranganathan C, Larsen PR. Oral thyroxine: Variation in biologic action and tablet content. Ann Intern Med. 1984;100:641-645
27. Werner SC. Treatment. In: Werner SC, Ingbar SH, eds. The Thyroid a Fundamental and Clinical Text. 4th ed. Baltimore, MD: Harper& Row, Publishers, Inc.; 1978:965-970
28. Fish LH, Schwartz HL, Cavanaugh J, Steffes MW, Bantle JP, Oppenheimer JH. Replacement dose, metabolism, and bioavailability of levothyroxine in the treatment of hypothyroidism. Role of triiodothyronine in pituitary feedback in humans. N Engl J Med. 1987; 316:764-770
29. Woeber KA. Levothyroxine therapy and serum free thyroxine and free triiodothyronine concentrations. J Endocrinol Investig. 2002; 25:106-109
30. Jonklaas J, Davidson B, Bhagat S, Soldin SJ. Triiodothyronine levels in athyreotic individuals during levothyroxine therapy. JAMA. 2008;299:769-777
31. Geffner DL, Azukizawa M, Hershman JM. Propylthiouracil blocks extrathyroidal conversion of thyroxine to triiodothyronine and augments thyrotropin secretion in man. J Clin Invest. 1975;55:224-229
32. Lartey LJ, Werneck-de-Castro JP, I OS, Unterman TG, Bianco AC. Coupling between nutrient availability and thyroid hormone activation. J Biol Chem. 2015;290:30551-30561